Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2000
03/07/2000US6034135 Delivering anionic macromolecule to cell
03/07/2000US6034072 Genetic engineering; anticancer, antitumor agent
03/07/2000US6034063 Human phosphatidylinositol transfer protein gamma
03/07/2000US6034061 Forming chondrocyte tissue in animal; administering bone morphogenic protein
03/07/2000US6034060 Peptide having an ability to promote the activation of protein C by thrombin
03/07/2000US6033913 Detection of ligand Interaction with polymeric material
03/07/2000US6033910 Antisense inhibition of MAP kinase kinase 6 expression
03/07/2000US6033908 Packaging systems for human recombinant adenovirus to be used in gene therapy
03/07/2000US6033905 Gibbon ape leukemia virus-based retroviral vectors
03/07/2000US6033904 Recombinant swinepox virus
03/07/2000US6033903 Method of expressing and secreting soluble extracellular domains of human gonadotropin hormone receptors
03/07/2000US6033902 Vector comprising a replication competent HIV-1 provirus and a heterologous gene
03/07/2000US6033900 The use of a rhamnogalacturonase for degradation or modification of plant cell materials for increasing digestablility of animal feeds.
03/07/2000US6033898 Enhanced yeast expression using regulatory control sequences from yeast sorbitol dehydrogenase gene
03/07/2000US6033895 Process for isolating and purifying viruses, soluble proteins and peptides from plant sources
03/07/2000US6033894 Kaposi's Syndrome Herpesvirus protease and assembly protein compositions and methods
03/07/2000US6033893 Use of these sequences in the diagnosis, prevention, and treatment of disorders associated with cell proliferation.
03/07/2000US6033892 Polypeptides having 5-aminolevulinic acid synthase activity and nucleic acids encoding same
03/07/2000US6033890 Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases
03/07/2000US6033889 The protein is used as a necessary medicament in treatment of inflammation, disease of autoimmunization,or chromosome lesion.
03/07/2000US6033886 Recombinant infectious non-segmented negative strand RNA virus
03/07/2000US6033885 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
03/07/2000US6033884 Delivering nucleic acid into a cell.
03/07/2000US6033883 Production of polyketides in bacteria and yeast
03/07/2000US6033882 Chiral synthesis of 2-hydroxy carboxylic acids with a dehydrogenase
03/07/2000US6033881 Method for one step isothermal non-transcription based amplification of nucleic acids
03/07/2000US6033880 Nucleic acid amplification reaction apparatus and method
03/07/2000US6033878 Protein-bound magnetic particles and process of producing the same
03/07/2000US6033877 Peptide expression and delivery system
03/07/2000US6033876 The antibodies may be used for diagnosis, or conjugated to a toxin to produce an immunotoxin.
03/07/2000US6033875 Method of improved production of insulin-like growth factor
03/07/2000US6033874 CRY1C polypeptides having improved toxicity to lepidopteran insects
03/07/2000US6033872 Polynucleotides encoding a novel human 11cb splice variant
03/07/2000US6033870 Human transmembrane protein
03/07/2000US6033869 Diagnosis, prevention, and treatment of disorders associated with aberrant cellular development and differentiation and inflammation.
03/07/2000US6033865 Human n-methyl-d-aspartate receptor type 1 subunits, DNA encoding same and uses therefor
03/07/2000US6033863 Monoclonal antibodies for selective immunological determination of high molecular weight, intact laminin forms in body fluids
03/07/2000US6033860 Screening a drug for deleterious side effects on a cell.
03/07/2000US6033856 Promoter of the cdc25B gene, its preparation and use
03/07/2000US6033851 Method for suppressing nonspecific hybridization in primer extension method
03/07/2000US6033850 Electrochemical denaturation of double-stranded nucleic acid
03/07/2000US6033849 Identification of such genes is critical for diagnosis, prognosis, and course of therapy.
03/07/2000US6033847 InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof
03/07/2000US6033823 Mutated penicillin G acylase genes
03/07/2000US6033670 Recombinant live avian vaccine, using as vector the avian infectious laryngotracheitis virus
03/07/2000US6033668 Chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
03/07/2000CA2190072C Fluorescence polarization detection of nucleic acid amplification
03/07/2000CA2175892C Kinase receptor activation assay
03/07/2000CA1340921C Purified thermostable enzyme
03/04/2000CA2281987A1 Method for supporting dna-fixation and dna-fixed support
03/02/2000WO2000011478A1 Assays, methods and means for modulating nuclear localisation
03/02/2000WO2000011446A2 Signal generating oligonucleotide-based biosensor
03/02/2000WO2000011223A1 Use of pooled probes in genetic analysis
03/02/2000WO2000011222A1 Methods of screening nucleic acids for nucleotide variations
03/02/2000WO2000011221A1 Method for determining polynucleotide sequence variations
03/02/2000WO2000011220A1 Fluorescence polarization in nucleic acid analysis
03/02/2000WO2000011219A1 Subtle mitochondrial mutations as tumor markers
03/02/2000WO2000011217A1 Compounds and methods for enhancing delivery of free polynucleotide
03/02/2000WO2000011216A1 Method of screening for compounds that modulate the activity of a molecular target
03/02/2000WO2000011213A1 Fluorescent probe and method for quantitating inositol triphosphate by using the same
03/02/2000WO2000011212A1 Enzyme activity screen with direct substrate reloading
03/02/2000WO2000011211A1 Enzyme activity screen with substrate replacement
03/02/2000WO2000011207A1 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS
03/02/2000WO2000011204A2 Homer interacting proteins
03/02/2000WO2000011202A1 Cationic complexes of polymer-modified adenovirus
03/02/2000WO2000011201A1 Targeted alphavirus and alphaviral vectors
03/02/2000WO2000011200A2 Plant expression vectors
03/02/2000WO2000011199A1 COMPOSITIONS AND METHODS FOR ALTERING AN ACETYL-CoA METABOLIC PATHWAY OF A PLANT
03/02/2000WO2000011198A1 Reduction of bowman-birk protease inhibitor levels in plants
03/02/2000WO2000011197A1 Nucleic acids having promoter activity and transgenic plants containing the same
03/02/2000WO2000011196A1 Polynucleotide sequences
03/02/2000WO2000011195A1 C-myc is activated by beta-catenin and tcf-4
03/02/2000WO2000011194A1 Cyclophilin-type peptidyl-prolyl cis/trans isomerase
03/02/2000WO2000011193A1 Novel proteases and dnas encoding the same
03/02/2000WO2000011192A2 Plant glutamine: fructose-6-phosphate amidotransferase nucleic acids
03/02/2000WO2000011191A2 Tpl-2/cot kinase and methods of use
03/02/2000WO2000011190A2 UDP-N-ACETYL GLUCOSAMINYL: β1,4 GALACTOSIDE: β1,3N-ACETYL GLUCOSAMINYL TRANSFERASE (POLYLACTOSAMINYL TYPE)
03/02/2000WO2000011189A1 Use of leu a promoter of stagonospora nodorum in screening method for fungicides
03/02/2000WO2000011188A1 Transgenic microbial polyhydroxyalkanoate producers
03/02/2000WO2000011187A1 Molecular sequence of swine retrovirus and methods of use
03/02/2000WO2000011186A1 Modified hcv peptide vaccines
03/02/2000WO2000011185A2 Improved expression of cry3b insecticidal protein in plants
03/02/2000WO2000011184A1 Staphylococcus aureus polypeptides
03/02/2000WO2000011183A2 Chlamydia antigens and corresponding dna fragments and uses thereof
03/02/2000WO2000011182A1 Basb024 outer membrane protein of neisseria meningitidis
03/02/2000WO2000011181A1 NUCLEIC ACID MOLECULES ENCODING INCLUSION MEMBRANE PROTEIN C OF $i(CHLAMYDIA)
03/02/2000WO2000011180A1 NUCLEIC ACID MOLECULES ENCODING POMP91A PROTEIN OF $i(CHLAMYDIA)
03/02/2000WO2000011179A1 RECOMBINANT MULTIVALENT MALARIAL VACCINE AGAINST $i(PLASMODIUM FALCIPARUM)
03/02/2000WO2000011178A2 An antifungal protein from tall fescue and its use in plant disease control
03/02/2000WO2000011177A1 Seed-preferred promoters
03/02/2000WO2000011176A2 Genes for plant fatty acid modifying enzymes associated with conjugated double bond formation
03/02/2000WO2000011175A1 Genetic method for the expression of polyproteins in plants
03/02/2000WO2000011174A1 Human il-1 epsilon dna and polypeptides
03/02/2000WO2000011173A1 Leptin-related peptides
03/02/2000WO2000011172A1 Antithrombin nucleotides and proteins from horn fly
03/02/2000WO2000011171A2 Human rna-associated proteins
03/02/2000WO2000011170A1 14400 receptor, a g-protein coupled receptor
03/02/2000WO2000011169A2 Human cell signaling proteins (csig)
03/02/2000WO2000011168A2 Genes that regulate hematopoietic blood forming stem cells and uses thereof
03/02/2000WO2000011167A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof